Growth Metrics

Lemaitre Vascular (LMAT) Receivables - Net (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Receivables - Net for 16 consecutive years, with $33.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Receivables - Net rose 11.8% to $33.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $33.6 million, a 11.8% increase, with the full-year FY2025 number at $33.6 million, up 11.8% from a year prior.
  • Receivables - Net was $33.6 million for Q4 2025 at Lemaitre Vascular, up from $32.4 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $36.5 million in Q2 2025 to a low of $19.5 million in Q3 2021.
  • A 5-year average of $26.3 million and a median of $25.2 million in 2023 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: decreased 0.63% in 2021, then soared 35.12% in 2024.
  • Lemaitre Vascular's Receivables - Net stood at $19.6 million in 2021, then increased by 12.27% to $22.0 million in 2022, then rose by 13.72% to $25.1 million in 2023, then grew by 19.94% to $30.1 million in 2024, then increased by 11.8% to $33.6 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Receivables - Net are $33.6 million (Q4 2025), $32.4 million (Q3 2025), and $36.5 million (Q2 2025).